For Which Children with ADHD is TBR Neurofeedback Effective? Comorbidity as a Moderator
Autor: | Michelle E. Roley-Roberts, Xueliang Pan, Rachel Bergman, Yubo Tan, Kyle Hendrix, Roger deBeus, Cynthia Kerson, Martijn Arns, Nadja R. Ging Jehli, Shea Connor, Constance Schrader, L. Eugene Arnold |
---|---|
Rok vydání: | 2022 |
Předmět: | |
Zdroj: | Applied Psychophysiology and Biofeedback. 48:179-188 |
ISSN: | 1573-3270 1090-0586 |
DOI: | 10.1007/s10484-022-09575-x |
Popis: | Introduction: We examined psychiatric comorbidities moderation of a 2-site double-blind randomized clinical trial of theta/beta-ratio (TBR) neurofeedback (NF) for attention deficit hyperactivity disorder (ADHD). Methods:Seven-to-ten-year-olds with ADHD received either NF (n=84) or Control (n=58) for 38 treatments. Outcome was change in parent-/teacher-rated inattention from baseline to end-of-treatment (acute effect), and 13-month-follow-up. Seventy percent had at least one comorbidity: oppositional defiant disorder (ODD) (50%), specific phobias (27%), generalized anxiety (23%), separation anxiety (16%). Comorbidities were grouped into anxiety alone (20%), ODD alone (23%), neither (30%), or both (27%). Results: Comorbidity (p=0.043) moderated acute effect; those with anxiety-alone responded better to Control than to TBR NF (d=-0.79, CI -1.55- -0.04), and the other groups showed a slightly better response to TBR NF than to Control (d=0.22~0.31, CI -0.3-0.98). At 13-months, ODD-alone group responded better to NF than Control (d=0.74, CI 0.05-1.43). Discussion: TBR NF is not indicated for ADHD with comorbid anxiety but may benefit ADHD with ODD. |
Databáze: | OpenAIRE |
Externí odkaz: |